Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2020 Jan 25;106(5):998–1009. doi: 10.1016/j.ijrobp.2019.12.038

Figure 2.

Figure 2.

Patient with a cT3N2M0 mid-esophageal squamous cell carcinoma with a pathologic complete response to neoadjuvant chemoradiotherapy (TRG 1). 18F-FDG PET images (A, E, I), fused PET/CT images (B, F, J), diffusion-weighted images (b-value = 200 s/mm2) (C, G, K) and T2 weighted images (D, H, L) on a 1.5T MR scanner before neoadjuvant chemoradiotherapy (nCRT) (A-D), during nCRT (E-H), and after nCRT (I-L).